KIT Promotes Tumor Stroma Formation and Counteracts Tumor-Suppressive TGFβ Signaling in Colorectal Cancer

Investigators employed genome-editing technologies in patient-derived organoids to study receptor tyrosine kinase KIT function in colorectal cancer in vitro and in vivo.